Ectopic pregnancy

Oct 21, 2019

Bayer Submits Supplemental New Drug Application to FDA for Intrauterine Device (IUD) Mirena® (levonorgestrel-releasing intrauterine system) 52 mg

May 06, 2019

Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the U.S.

Dec 10, 2018

Newly Published Data from Phase 3 Clinical Trial of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg Confirms Efficacy, Safety, and Tolerability Through Five Years

Oct 16, 2018

FDA Approves Medicines360's sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years

May 07, 2018

Medicines360, WCG, and Population Services International Announce Launch of AVIBELA(TM) Hormonal Intrauterine System in Madagascar

Apr 30, 2018

Medicines360 and Allergan Present 5-Year Trial Data from Largest On-going IUS Clinical Study

Apr 26, 2018

Allergan to Present New Data at the American College of Obstetrics and Gynecology 67th Annual Clinical and Scientific Meeting 2018

Feb 22, 2018

FDA Acceptance of Medicines360's Filing for supplemental New Drug Application for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg